Regulatory elements of replication timing and 3D genome organization
Regulatory elements of replication timing and 3D genome organization
批准号:
10640264
负责人:
Juan Carlos Rivera-Mulia
金额:
$38.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-01 至 2025-06-30
关键词:
3-DimensionalBindingCell Differentiation processCell NucleusCellsChromatinComputer ModelsDNA Replication TimingDevelopmentDiseaseElementsEnhancersEpigenetic ProcessEvolutionExperimental DesignsGene ExpressionGenomeGenome engineeringGenomicsHumanHuman GenomeImageLaboratoriesMinnesotaMissionModelingMusNational Institute of General Medical SciencesPositioning AttributePublic HealthRegulatory ElementResearchResource SharingResourcesSupercomputingSystemTechnologyTestingThree-dimensional analysisTrans-ActivatorsUniversitiesWorkbioinformatics toolcell typedifferentiation protocolembryonic stem cellexperimental analysisgene functiongene regulatory networkgenome editinghuman embryonic stem cellimaging facilitiesinnovationnext generation sequencingpluripotencystem cell differentiationstem cellssuccesstranscription factor
中文摘要
项目摘要
越来越多的证据表明,需要三维(3D)基因组组织来调节
基因功能及其改变与许多疾病有关。基因组被组织成
与DNA复制的时间顺序(复制定时- RT)对齐的区室。然而,在这方面,
关于3D基因组组织的基本机制知之甚少。最近,我们发现
RT和3D基因组组织控制元件(早期复制控制元件-ERCE),
小鼠胚胎干细胞ERCE富含增强子表观遗传标记,形成强染色质
在一些实施方案中,多能性蛋白与多能性特异性转录因子相互作用并被多能性特异性转录因子结合。此外,我开发了一个
预测细胞类型特异性共占据基因调控网络的整合模型
转录因子调控RT,在此,我们将研究基因组的调控元件
组织在人类分化的细胞类型,调查如何反式作用因子控制这些
元素,并定义了3D基因组组织在发育和进化过程中如何重塑。
我们的中心假设是,ERCE中细胞类型特异性转录因子的共同占据
是调节3D基因组结构所必需的。为了验证这一假设,我们将删除和插入
将候选ERCE插入人分化细胞类型的基因组中,并测试它们对RT、3D
基因组组织和基因表达。我们将使用高度同步的
人胚胎干细胞分化系统。最后,我们将分析3D基因组组织
利用来自不同物种的原代细胞进行进化。我的实验室有着独特的优势
在实验设计和3D分析方面具有广泛的专业知识,
基因组组织在人类细胞命运的承诺。此外,
明尼苏达大学将促进该项目的成功,包括最先进的
基因组编辑技术(基因组工程共享资源),下一代测序
(基因组学中心),干细胞(干细胞研究所),成像(成像中心)和生物信息学工具
明尼苏达超级计算研究所(Minnesota Supercomputing Institute)我们希望我们的工作将有助于理解
基因组组织的基本原则及其与基因功能的关系。拟议
研究结合了几个创新方面,如综合计算模型,以预测
大规模染色质组织的调控元件,基因组工程技术和
优化人类胚胎干细胞的分化方案,以剖析
控制发育和进化过程中的3D基因组组织。
英文摘要
PROJECT SUMMARY
Increasing evidence indicates that three-dimensional (3D) genome organization is required to regulate
gene function and its alterations are associated with many diseases. The genome is organized into
compartments that align with the temporal order of DNA replication (replication timing – RT). However,
little is known about the mechanisms underlying 3D genome organization. Recently, we identified cis
elements of RT and 3D genome organization control (early replicating control elements – ERCEs) in
murine embryonic stem cells. ERCEs are enriched in enhancer epigenetic marks, form strong chromatin
interactions and are bound by pluripotency-specific transcription factors. Moreover, I developed an
integrative model of gene regulatory networks that predicts that co-occupancy of cell type-specific
transcription factors regulate RT. Here, we will study what are the regulatory elements of genome
organization in human differentiated cell types, investigate how trans-acting factors control these
elements, and define how 3D genome organization is remodeled during development and evolution.
Our central hypothesis is that co-occupancy of cell type-specific transcription factors at ERCEs
is required to regulate the 3D genome organization. To test this hypothesis, we will delete and insert
candidate ERCEs into the genome of human differentiated cell types and test their effect on RT, 3D
genome organization and gene expression. We will track ERCE activation using highly-synchronous
human embryonic stem cells differentiation systems. Finally, we will analyze 3D genome organization
evolution using primary cells derived from different species. My laboratory is uniquely positioned to
perform the proposed research with broad expertise in the experimental design and analysis of 3D
genome organization during human cell fate commitment. Moreover, numerous resources available at
the University of Minnesota will facilitate the success of this project, including state-of-the-art
technologies for genome editing (Genome Engineering Shared Resource), next-generation sequencing
(Genomics Center), stem cells (Stem Cell Institute), imaging (Imaging Center) and bioinformatic tools
(Minnesota Supercomputing Institute). We expect that our work will contribute significantly to understand
the fundamental principles of genome organization and its relationship to gene function. The proposed
research combines several innovative aspects such as integrative computational models to predict
regulatory elements of large-scale chromatin organization, genome engineering technologies and
optimized differentiation protocols of human embryonic stem cells to dissect the mechanisms that
control 3D genome organization during development and evolution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulatory elements of replication timing and 3D genome organization
-
批准号:10424494
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2020
-
负责人:Juan Carlos Rivera-Mulia
-
依托单位:
Regulatory elements of replication timing and 3D genome organization
-
批准号:10387585
-
项目类别:
-
资助金额:$19.74万
-
财政年份:2020
-
负责人:Juan Carlos Rivera-Mulia
-
依托单位:
Regulatory elements of replication timing and 3D genome organization
-
批准号:10205115
-
项目类别:
-
资助金额:$38.66万
-
财政年份:2020
-
负责人:Juan Carlos Rivera-Mulia
-
依托单位:
Regulatory elements of replication timing and 3D genome organization
-
批准号:10796564
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2020
-
负责人:Juan Carlos Rivera-Mulia
-
依托单位:
Regulatory elements of replication timing and 3D genome organization
-
批准号:10027344
-
项目类别:
-
资助金额:$37.8万
-
财政年份:2020
-
负责人:Juan Carlos Rivera-Mulia
-
依托单位:
Regulatory elements of replication timing and 3D genome organization
-
批准号:10808426
-
项目类别:
-
资助金额:$1.01万
-
财政年份:2020
-
负责人:Juan Carlos Rivera-Mulia
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: